Resources
Events

LSPN North American Boston 2022 - Protecting and Leveraging Innovation in the Life Sciences

May 12, 2022 at 11:00am
Lin J. Hymel
Boston, MA

Join Verrill's Lin Hymel and Dean Phelps at the Annual Life Sciences Patent Network North America conference where they will be moderating a roundtable discussion on Patenting Biotech and Pharmaceutical Inventions Involving Artificial Intelligence. There will be an in-house patent counsel from established and fledgling pharmaceutical and biotechnology companies coming together to listen to updates on patent prosecution and enforceability from global jurisdictions, meet in informal discussion groups, and source specialist IP attorneys who can assist them with their IP portfolio strategies over the coming year. The Boston conference takes a broad global view of the patent protection landscape and then delves deeper into the topics of specific current interest. Extended round table discussion groups enable a couple of hours to be spent in small groups, sharing views on a range of topics of the delegates’ choosing. For fledgling bio-pharma manufacturers, the conference features a hugely popular open clinic to enable in-house counsel to quiz specialist private patent attorneys from around the globe on their own specific pressing patent issues. Verrill is a proud sponsor of this event.

For more information and to register for this event, please click here.

Firm Highlights

Publication/Podcast

State Trademark Registration

The United States has two levels of trademark registration: state and federal. A state trademark registration is issued by a state office and protects a trademark only in that state, whereas a federal trademark...

Event

American Health Law Association's Fraud and Compliance Forum

Verrill's David Lazarus will speaking at the American Health Law Association Fraud and Compliance Forum on September 27-29 in Baltimore, Maryland. David's panel, Enforcement Trends in the AKS, EKRA, FCA and more–plus How to...

Publication/Podcast

CMS Proposes to Make Lump-Sum Payments to Hospitals for Underpayments for Drugs Purchased Through the 340B Program During 2018-2022

Last week CMS issued its anticipated proposed rule to implement the Supreme Court’s decision last year which ruled that CMS’ reduction in Medicare payments for Part B outpatient drugs purchased through the 340B program...

News

Verrill Welcomes Intellectual Property Partner Patrick Duplessis, Enhancing the Firm’s Highly Sophisticated Patent Practice

Publication/Podcast

The PHE is Ending: Do You Know Where Your Waivers Are?

While the pandemic is not over, the COVID-19 public health emergency (PHE) is expected to expire soon, which means that a number of operational, safety, and billing standards that were waived at the beginning...

News

Verrill Welcomes William Ryann to Firm’s Intellectual Property Group

Publication/Podcast

Speaking of Health Law Podcast with David Lazarus

Verrill Partner David Lazarus was a recent guest on the AHLA’s Speaking of Health Law podcast. The episode featured industry leaders discussing some of the key takeaways of the Schutte v. SuperValu, Inc. case...

Contact Verrill at (855) 307 0700